Patrick Nadol1,2, Siobhan O'Connor3, Hao Duong1, Tonya Mixson-Hayden3, Tran Hong Tram4, Guo-Liang Xia3, John Kaldor2, Matthew Law2, Tuan Nguyen4. 1. Division of Global HIV/AIDS, U.S. Centers for Disease Control and Prevention, Hanoi, Vietnam. 2. Kirby Institute for Infection and Immunity, University of New South Wales, Sydney, Australia. 3. Division of Viral Hepatitis, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia, USA. 4. National Institute of Hygiene and Epidemiology, Hanoi, Vietnam.
Abstract
BACKGROUND: Hepatitis C virus (HCV) is an increasing health issue among key populations such as men who have sex with men (MSM). We sought to assess the burden of and risk factors for HCV among MSM in Vietnam. METHODS: We analysed behavioural and demographic data and stored specimens from MSM surveyed in four provinces through Vietnam's 2009-2010 Integrated Biologic and Behavioural Survey, which used probability-based, respondent-driven sampling. Commercial hepatitis B surface antigen (HBsAg) and HCV/antibody (HCV Ag/Ab) testing were performed on archived sera with follow-up PCR for HCV RNA and genotype determination. RESULTS: Among the 1588 MSM surveyed, the median (range) frequency, by province, of HCV Ag/Ab detection was 28.4% (13.7%-38.8%); 84.5% (83.1%-100%) among HIV-infected and 21.9% (8.9%-28.2%) among HIV-uninfected. HCV prevalence was higher in northern Hanoi and Hai Phong provinces than in southern Ho Chi Minh City and Chan Tho provinces. Among a convenience sample of 67 HCV Ag/Ab+ MSM, 67.2% were HCV RNA+; of 41 genotyped, 73.2% were genotype 1. HBsAg prevalence varied from 8.5% to 27.4%. In the multivariable logistic regression analysis, being HIV-infected (adjusted OR (aOR) 19.0; 7.0-51.9), ever having used injected drugs (aOR 4.4; 1.6-12.4) and age >25 years were significant risk factors for testing HCV Ag/Ab+. CONCLUSIONS: HCV infection in Vietnam appears to be high among MSM, particularly among HIV-infected MSM, with a north-south gradient. Given overlapping risk behaviours and associations between HCV and HIV, integrating HIV and HCV programme services to prevent both HIV and HCV transmission among MSM is indicated. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.
BACKGROUND:Hepatitis C virus (HCV) is an increasing health issue among key populations such as men who have sex with men (MSM). We sought to assess the burden of and risk factors for HCV among MSM in Vietnam. METHODS: We analysed behavioural and demographic data and stored specimens from MSM surveyed in four provinces through Vietnam's 2009-2010 Integrated Biologic and Behavioural Survey, which used probability-based, respondent-driven sampling. Commercial hepatitis B surface antigen (HBsAg) and HCV/antibody (HCV Ag/Ab) testing were performed on archived sera with follow-up PCR for HCV RNA and genotype determination. RESULTS: Among the 1588 MSM surveyed, the median (range) frequency, by province, of HCV Ag/Ab detection was 28.4% (13.7%-38.8%); 84.5% (83.1%-100%) among HIV-infected and 21.9% (8.9%-28.2%) among HIV-uninfected. HCV prevalence was higher in northern Hanoi and Hai Phong provinces than in southern Ho Chi Minh City and Chan Tho provinces. Among a convenience sample of 67 HCV Ag/Ab+ MSM, 67.2% were HCV RNA+; of 41 genotyped, 73.2% were genotype 1. HBsAg prevalence varied from 8.5% to 27.4%. In the multivariable logistic regression analysis, being HIV-infected (adjusted OR (aOR) 19.0; 7.0-51.9), ever having used injected drugs (aOR 4.4; 1.6-12.4) and age >25 years were significant risk factors for testing HCV Ag/Ab+. CONCLUSIONS:HCV infection in Vietnam appears to be high among MSM, particularly among HIV-infected MSM, with a north-south gradient. Given overlapping risk behaviours and associations between HCV and HIV, integrating HIV and HCV programme services to prevent both HIV and HCV transmission among MSM is indicated. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.
Authors: Bao Ngoc Vu; Kim Do Tuan; An Khanh Tran; Long Khanh Tran; Kimberly Green; Khoa Trong Nguyen; Phuong Duc Cao Journal: Clin Liver Dis (Hoboken) Date: 2022-04-29
Authors: Alessandra Berto; Jeremy Day; Nguyen Van Vinh Chau; Guy E Thwaites; Ngoc Nghiem My; Stephen Baker; Thomas C Darton Journal: BMC Infect Dis Date: 2017-04-11 Impact factor: 3.090
Authors: Thomas Fitzpatrick; Kali Zhou; Yu Cheng; Po-Lin Chan; Fuqiang Cui; Weiming Tang; Katie R Mollan; Wilson Guo; Joseph D Tucker Journal: BMC Infect Dis Date: 2018-09-29 Impact factor: 3.090
Authors: Linh Thuy Nguyen; Van Thi Thuy Nguyen; Kim Anh Le Ai; Minh Binh Truong; Tam Thi Minh Tran; Muhammad S Jamil; Cheryl Johnson; Elena Ivanova Reipold; Philippa Easterbrook; Kidong Park Journal: Diagnostics (Basel) Date: 2021-02-23
Authors: Thanh V Kim; Duc H Le; Diem V B Dao; Trang Ngoc Doan Pham; Gary W Mize; Loc T B Phan; Dan X Nguyen; Thi-Thuy-Dung Ngo; Robert G Gish; William M Lee; Amy Trang; Anh N Le; Moon Chen; Hai T Phan; Binh T Nguyen; Hong K Tang; Doan Y Dao Journal: Lancet Reg Health West Pac Date: 2022-07-09
Authors: Linh-Vi N Le; Siobhan O'Connor; Tram Hong Tran; Lisa Maher; John Kaldor; Keith Sabin; Hoang Vu Tran; Quang Dai Tran; Van Anh Thi Ho; Tuan Anh Nguyen Journal: Western Pac Surveill Response J Date: 2019-07-25